• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or keep ADHD medications during breastfeeding and pregnancy is challenging for women with the condition. There is a lack of information about how long-term exposure to these medications can affect the fetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological issues such as hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality studies.

Risk/Benefit Analysis

Women who are pregnant and Adhd Medication Pregnancy taking ADHD medications must weigh the advantages of using them against the risks to the fetus. The doctors don't have the information to provide clear recommendations however they can provide information on risks and benefits to aid pregnant women in making informed decisions.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during early pregnancy did not have a higher risk of fetal malformations or structural birth defects. Researchers conducted a large population-based case-control study to determine the prevalence of major structural birth defects in infants born to mothers who took stimulants during the early stages of pregnancy, as well as those who had not. Pediatric cardiologists, clinical geneticists and other experts reviewed the cases in order to make sure that the classification was correct and to reduce any bias.

The study of the researchers was not without limitations. The most important issue was that they were unable to distinguish the effects of the medication from the disorder that is underlying. This limitation makes it difficult to know whether the limited associations observed in the groups that were exposed result from medication use or confounding by comorbidities. In addition the researchers did not examine long-term offspring outcomes.

The study did find that infants whose mothers took ADHD medications during pregnancy were at a slightly more risk of being admitted to the neonatal intensive care unit (NICU) than infants who were born without any medication or had cut back on their medications prior to or during pregnancy. The reason for this was central nervous system-related disorders and the higher risk of admission was not found to be influenced by which stimulant medications were used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher chance of having an emergency caesarean section or having a baby that scored low on the Apgar scale (less than 7). These increases appear to be independent of the type of medication taken during pregnancy.

The researchers suggest that the low risk associated with the use of ADHD medications during the early stages of pregnancy may be offset by the higher benefit to both the mother and child of continued treatment for [Redirect Only] the woman's disorder. Physicians should discuss the issue with their patients and, if possible, assist them in developing strategies to improve coping skills that can lessen the impact of her disorder on her daily functioning and relationships.

Medication Interactions

More and more doctors are confronted with the dilemma of whether to maintain treatment or stop during pregnancy as more women are diagnosed with ADHD. These decisions are usually made without clear and authoritative evidence. Instead, physicians must take into account their own experience in conjunction with the experiences of other doctors, and the research on the topic.

The issue of possible risks to infants is difficult to determine. Many studies on this topic are based on observational data rather than controlled research, and their conclusions are often contradictory. Most studies restrict their analysis to live births, which may underestimate the teratogenic impact leading to abortions or terminations of pregnancy. The study discussed in this journal club addresses these shortcomings by analyzing data on live and deceased births.

The conclusion: While certain studies have demonstrated a positive association between ADHD medications and the risk of certain birth defects, other studies have found no such relationship and the majority of studies show a neutral or even slight negative effect. In every case it is imperative to conduct a thorough study of the benefits and risks must be performed.

For a lot of women with ADHD, the decision to discontinue medication can be difficult, if not impossible. In fact, in a recent article in Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of loneliness and family conflict for those suffering from the disorder. Furthermore, a loss of medication may affect the ability to perform jobs and drive safely, which are important aspects of a normal life for many people suffering from ADHD.

She recommends women who are uncertain about whether to continue or discontinue medication due to their pregnancy, consider educating family members, friends, and coworkers on the condition, its effects on daily functioning, and on the benefits of keeping the current treatment regimen. It can also make the woman feel more comfortable in her struggle with her decision. Some medications can pass through the placenta. If a woman decides to not take her ADHD medication while pregnant and breastfeeding, it is crucial to be aware that the medication could be transferred to the infant.

Risk of Birth Defects

As the use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (adhd medication Cost) increases there are concerns over the impact that these drugs could have on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this subject. Utilizing two huge data sets, researchers were able to look at more than 4.3 million pregnancies and see whether stimulant medications increased the risk of birth defects. While the overall risk remains low, the scientists discovered that the first-trimester exposure to ADHD medicines was associated with an increased risk of specific heart defects, such as ventriculoseptal defect (VSD).

The researchers of the study did not discover any connection between early medication usage and other congenital anomalies like facial deformities, or club feet. The findings are in line with previous studies revealing a small but significant increase in the risk of heart malformations in women who started taking ADHD medications prior to the time of the birth of their child. This risk increased during the latter part of pregnancy, as many women are forced to stop taking their ADHD medications.

Women who took ADHD medication for adhd and anxiety in the first trimester were more likely require a caesarean birth or have an insufficient Apgar after delivery, and have a baby who needed help breathing when they were born. However the authors of the study were not able to eliminate bias due to selection by restricting the study to women who did not have any other medical conditions that could have contributed to these findings.

Researchers hope that their study will help doctors when they encounter pregnant women. They advise that while the discussion of the benefits and risks is important, the decision to stop or continue treatment should be based on the woman's needs and the severity of her ADHD symptoms.

The authors also advise that while discontinuing the medications is an option, it isn't an option that is recommended due to the high prevalence of depression and other mental health problems among women who are pregnant or who are recently post-partum. Further, the research suggests that women who choose to stop taking their medication are more likely to experience a difficult time getting used to life without them after the baby's arrival.

Nursing

It can be overwhelming becoming a mother. Women with ADHD who must work through their symptoms while attending physician appointments and preparing for the arrival of a baby and getting used to new routines at home can experience severe challenges. Many women choose to continue taking their adhd medication pregnancy medication during pregnancy.

The risk for breastfeeding infant is minimal because the majority of stimulant medication is absorbed through breast milk at a low estrogen and adhd medication level. The rate of medication exposure will vary based on the dosage and frequency of administration as well as the time of day. Additionally, individual medications enter the infant's system differently through the gastrointestinal tract and breast milk. The impact of this on a newborn infant is not yet fully understood.

Due to the absence of research, some physicians may recommend stopping stimulant medications during the course of pregnancy. It's a difficult choice for the mother, who must weigh the advantages of continuing her medication against the risks to the foetus. As long as more information is available, doctors may ask pregnant patients if they have an background of does adhd medication work or if they are planning to take medication during the perinatal phase.

A increasing number of studies have proven that most women can safely continue taking their ADHD medication while they are pregnant and nursing. In response, an increasing number of patients are choosing to do this. They have found, in consultation with their doctor, that the benefits of continuing their current medication outweigh any risk.

Women with ADHD who are planning to nurse should seek advice from a specialist psychiatrist before becoming pregnant. They should discuss their medication with their doctor, and the pros and cons for continuing treatment. This includes non-pharmacological strategies. Psychoeducation is also required to help pregnant women suffering from ADHD understand the symptoms and underlying disorder. They should also learn about treatment options and build strategies for coping. This should be a multidisciplinary process including obstetricians, GPs and psychiatry. Counselling for pregnancy should include discussion of a management plan for both the mother as well as the child, and monitoring for signs of deterioration, and when necessary, making adjustments to the medication regimen.